New Functions of the Inositol Polyphosphate 5-Phosphatases in Cancer

Christophe Erneux1, Somadri Ghosh, Ana Raquel Ramos

  • 1Interdisciplinary Research Institute (IRIBHM), Université Libre de Bruxelles, Campus Erasme, Bldg C, 808 Route de Lennik, 1070 Brussels, Belgium. cerneux@ulb.ac.be.

Insights

Inositol 5-phosphatases regulate crucial cell signaling pathways. New activators and inhibitors offer potential treatments for cancer and inflammation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Inositol polyphosphate 5-phosphatases are enzymes acting on inositol phosphates and phosphoinositides.
  • They comprise 10 human isoenzymes and splice variants implicated in pathologies like cancer and genetic syndromes.
  • Unlike tumor suppressors PTEN and INPP4B, 5-phosphatases are often amplified in cancer cells.

Purpose of the Study:

  • To investigate the role of inositol 5-phosphatases in cellular signaling and human diseases.
  • To understand their involvement in phosphoinositide metabolism and its impact on cellular functions.
  • To explore the potential of novel modulators for therapeutic applications.

Main Methods:

  • Analysis of inositol 5-phosphatase activity and expression.
  • Investigation of phosphoinositide lipid signaling networks.
  • Identification and characterization of novel enzyme inhibitors and activators.

Main Results:

  • Inositol 5-phosphatases critically influence phosphoinositide levels, including PI(3,4,5)P3, PI(4,5)P2, and PI(3,4)P2.
  • The dephosphorylation of PI(3,4,5)P3 to PI(3,4)P2 generates a key signaling molecule for cell migration, invasion, and endocytosis.
  • These enzymes impact intracellular targets like protein kinase B (PKB/Akt) and actin-binding proteins.

Conclusions:

  • Inositol 5-phosphatases are vital regulators of cellular processes and are dysregulated in various human cancers.
  • Targeting these enzymes with new inhibitors or activators holds promise for treating inflammatory diseases and cancer.
  • Further research into this enzyme family could unveil new therapeutic strategies.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K